292 related articles for article (PubMed ID: 34808553)
1. Eugenosedin-A improves obesity-related hyperglycemia by regulating ATP-sensitive K
Lin RJ; Yen YK; Lee CH; Hsieh SL; Chang YC; Juan YS; Long CY; Shen KP; Wu BN
Biomed Pharmacother; 2022 Jan; 145():112447. PubMed ID: 34808553
[TBL] [Abstract][Full Text] [Related]
2. Eugenosedin-A improves glucose metabolism and inhibits MAPKs expression in streptozotocin/nicotinamide-induced diabetic rats.
Shen KP; Lin HL; Yen HW; Hsieh SL; An LM; Wu BN
Kaohsiung J Med Sci; 2018 Mar; 34(3):142-149. PubMed ID: 29475461
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness comparisons of eugenosedin-A, glibenclamide and pioglitazone on diabetes mellitus induced by STZ/NA and high-fat diet in SHR.
Lin HL; Cheng PW; Tu YC; Yeh BC; Wu BN; Shen KP
J Pharm Pharmacol; 2021 Apr; 73(6):835-845. PubMed ID: 33779726
[TBL] [Abstract][Full Text] [Related]
4. Impaired glucose sensitivity of ATP-sensitive K+ channels in pancreatic beta-cells in streptozotocin-induced NIDDM rats.
Tsuura Y; Ishida H; Okamoto Y; Tsuji K; Kurose T; Horie M; Imura H; Okada Y; Seino Y
Diabetes; 1992 Jul; 41(7):861-5. PubMed ID: 1612201
[TBL] [Abstract][Full Text] [Related]
5. Impaired glucose-stimulated insulin secretion and reduced β-cell mass in pancreatic islets of hyperthyroid rats.
Karbalaei N; Noorafshan A; Hoshmandi E
Exp Physiol; 2016 Aug; 101(8):1114-27. PubMed ID: 27060234
[TBL] [Abstract][Full Text] [Related]
6. Insulin stimulus-secretion coupling is triggered by a novel thiazolidinedione/sulfonylurea hybrid in rat pancreatic islets.
Mendes CP; Postal BG; Oliveira GTC; Castro AJG; Frederico MJS; Moraes ALL; Neuenfeldt PD; Nunes RJ; Menegaz D; Silva FRMB
J Cell Physiol; 2018 Jan; 234(1):509-520. PubMed ID: 29968920
[TBL] [Abstract][Full Text] [Related]
7. HCV affects K
Niu B; Ma L; Yao L; Zhang Y; Su H
Endocrine; 2024 May; 84(2):427-440. PubMed ID: 37962815
[TBL] [Abstract][Full Text] [Related]
8. Phorbol ester impairs electrical excitation of rat pancreatic beta-cells through PKC-independent activation of KATP channels.
Suga S; Wu J; Ogawa Y; Takeo T; Kanno T; Wakui M
BMC Pharmacol; 2001; 1():3. PubMed ID: 11560763
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide opens ATP-sensitive K+ channels through suppression of phosphofructokinase activity and inhibits glucose-induced insulin release in pancreatic beta cells.
Tsuura Y; Ishida H; Hayashi S; Sakamoto K; Horie M; Seino Y
J Gen Physiol; 1994 Dec; 104(6):1079-98. PubMed ID: 7699364
[TBL] [Abstract][Full Text] [Related]
10. The role of calcium in intracellular pathways of rutin in rat pancreatic islets: potential insulin secretagogue effect.
Kappel VD; Frederico MJ; Postal BG; Mendes CP; Cazarolli LH; Silva FR
Eur J Pharmacol; 2013 Feb; 702(1-3):264-8. PubMed ID: 23399767
[TBL] [Abstract][Full Text] [Related]
11.
Zambrana S; Lundqvist LCE; Mamani O; Catrina SB; Gonzales E; Östenson CG
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037028
[No Abstract] [Full Text] [Related]
12. Hydrogen sulphide reduces insulin secretion from HIT-T15 cells by a KATP channel-dependent pathway.
Ali MY; Whiteman M; Low CM; Moore PK
J Endocrinol; 2007 Oct; 195(1):105-12. PubMed ID: 17911402
[TBL] [Abstract][Full Text] [Related]
13. Dextromethorphan and Dextrorphan Influence Insulin Secretion by Interacting with K
Gresch A; Düfer M
J Pharmacol Exp Ther; 2020 Oct; 375(1):10-20. PubMed ID: 32665318
[TBL] [Abstract][Full Text] [Related]
14. KATP channel-deficient pancreatic beta-cells are streptozotocin resistant because of lower GLUT2 activity.
Xu J; Zhang L; Chou A; Allaby T; Bélanger G; Radziuk J; Jasmin BJ; Miki T; Seino S; Renaud JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E326-35. PubMed ID: 18042662
[TBL] [Abstract][Full Text] [Related]
15. Structural nucleotide analogs are potent activators/inhibitors of pancreatic β cell KATP channels: an emerging mechanism supporting their use as antidiabetic drugs.
Tricarico D; Rolland JF; Cannone G; Mele A; Cippone V; Laghezza A; Carbonara G; Fracchiolla G; Tortorella P; Loiodice F; Conte Camerino D
J Pharmacol Exp Ther; 2012 Feb; 340(2):266-76. PubMed ID: 22028392
[TBL] [Abstract][Full Text] [Related]
16. Decreasing cx36 gap junction coupling compensates for overactive KATP channels to restore insulin secretion and prevent hyperglycemia in a mouse model of neonatal diabetes.
Nguyen LM; Pozzoli M; Hraha TH; Benninger RK
Diabetes; 2014 May; 63(5):1685-97. PubMed ID: 24458355
[TBL] [Abstract][Full Text] [Related]
17. Possible New Strategies for the Treatment of Congenital Hyperinsulinism.
Sikimic J; Hoffmeister T; Gresch A; Kaiser J; Barthlen W; Wolke C; Wieland I; Lendeckel U; Krippeit-Drews P; Düfer M; Drews G
Front Endocrinol (Lausanne); 2020; 11():545638. PubMed ID: 33193079
[TBL] [Abstract][Full Text] [Related]
18. Block of pancreatic ATP-sensitive K+ channels and insulinotrophic action by the antiarrhythmic agent, cibenzoline.
Ishida-Takahashi A; Horie M; Tsuura Y; Ishida H; Ai T; Sasayama S
Br J Pharmacol; 1996 Apr; 117(8):1749-55. PubMed ID: 8732286
[TBL] [Abstract][Full Text] [Related]
19. Sulfonyl(thio)urea derivative induction of insulin secretion is mediated by potassium, calcium, and sodium channel signal transduction.
Sulis PM; Dambrós BF; Mascarello A; Dos Santos ARS; Yunes RA; Nunes RJ; Frederico MJS; Barreto Silva FRM
J Cell Physiol; 2019 Jul; 234(7):10138-10147. PubMed ID: 30417369
[TBL] [Abstract][Full Text] [Related]
20. Intracellular Ca(2+) modulation of ATP-sensitive K(+) channel activity in acetylcholine-induced activation of rat pancreatic beta-cells.
Nakano K; Suga S; Takeo T; Ogawa Y; Suda T; Kanno T; Wakui M
Endocrinology; 2002 Feb; 143(2):569-76. PubMed ID: 11796512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
